To confirm the importance of NR2F6 as T-cell-intrinsic suppressor of T-cell-mediated tumor growth control in vivo, we next employed ex vivo siRNA-mediated Nr2f6 silencing prior ACT of autologous T cells into a MC38 subcutaneous mouse tumor model. Here, NR2F6 is linked to neoplasm.